Dna X (SONM) Other Operating Expenses (2018 - 2025)

Dna X's Other Operating Expenses history runs 8 years deep, the most recent figure standing at -$11.9 million for Q4 2025.

• Quarterly Other Operating Expenses rose 52.44% year-over-year to -$11.9 million in Q4 2025, while the trailing twelve-month figure through Mar 2026 was -$8.5 million (up 61.51% YoY) and the FY2024 annual result came in at -$13.5 million, down 253.7% from the prior year.
• Other Operating Expenses was -$11.9 million for Q4 2025 at Dna X, down from $2.5 million in the prior quarter.
• Across five years, Other Operating Expenses topped out at $7.9 million in Q4 2023 and bottomed at -$24.9 million in Q4 2024.
• A 5-year average of -$313473.7 and a median of $909000.0 in 2025 frame the typical range for Other Operating Expenses.
• Annual changes were most pronounced in 2023 — Other Operating Expenses surged 670.0% — and 2025, when it tumbled 458.11%.
• Dna X's Other Operating Expenses stood at -$1.7 million in 2021, then surged by 173.13% to $1.2 million in 2022, then surged by 549.88% to $7.9 million in 2023, then plunged by 414.76% to -$24.9 million in 2024, then jumped by 52.44% to -$11.9 million in 2025.
• Business Quant data shows SONM's Other Operating Expenses at -$11.9 million in Q4 2025, $2.5 million in Q3 2025, and $909000.0 in Q2 2025.